Elastomeric Coating-Surface Integrity
This coating was developed in response to ongoing clinical concerns of complications associated with traditional DES surface quality and integrity.
The elastomeric coating and coating process ensure an exceptional surface quality and long-term coating integrity compared to pro-inflammatory cracking and peeling of durable polymers.
Elastomer-Based Coating
The first stent manufacturer to offer elastomer-based coating, Medinol eliminates the risks associated with cracking and peeling delivering a smooth elastic surface.
Improved Surface Quality
Improved surface quality and long-term coating integrity may promote clinical advantages such as better endothelialization, lower inflammation, lower stent thrombosis and restenosis rates.
Surface Elasticity & Smoothness
The coating’s surface elasticity and smoothness are enabled by Quality Surface™ – our proprietary manufacturing technology that creates a high-quality coating of stent panels with an elastomer and limus drug.
Uniform
Drug Release
Leveraging the highly-uniform WiZeCell scaffolding, which better conforms to vessel anatomy and moves naturally with the vessel, elastomeric coating technology enables long-term surface integrity as well as predictable, uniform release of a limus drug to the vessel wall.
